We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+14.35%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$1.53T
AUM Growth
+$160B
Cap. Flow
+$13.2B
Cap. Flow %
0.86%
Top 10 Hldgs %
25.16%
Holding
7,888
New
634
Increased
2,517
Reduced
3,216
Closed
856

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.54B
2
NVDA icon
NVIDIA
NVDA
+$5.22B
3
AAPL icon
Apple
AAPL
+$3.2B
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.51B
5
DIS icon
Walt Disney
DIS
+$2.15B

Sector Composition

Rank Sector Weight
1 Technology 24.6%
2 Financials 9.92%
3 Consumer Discretionary 9.63%
4 Communication Services 7.24%
5 Healthcare 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAL.WS icon
6426
Valaris Ltd Warrants
VAL.WS
$606M
0
SCD
6427
LMP Capital and Income Fund
SCD
$354M
$702 ﹤0.01%
45
-74
-62% -$1.14K
ADXN
6428
Addex Therapeutics
ADXN
$7.08M
$699 ﹤0.01%
+79
New +$639
EQX icon
6429
Equinox Gold
EQX
$7.43B
$696 ﹤0.01%
121
-172,450
-100% -$1.12M
PRPH
6430
DELISTED
ProPhase Labs
PRPH
$691 ﹤0.01%
177
-3
-2% -$10
STTK icon
6431
Shattuck Labs
STTK
$687M
$690 ﹤0.01%
871
-35,748
-98% -$34.7K
SPRO icon
6432
Spero Therapeutics
SPRO
$69.5M
$684 ﹤0.01%
236
-60,581
-100% -$87.1K
CLSD
6433
DELISTED
Clearside Biomedical
CLSD
$672 ﹤0.01%
56
-609
-92% -$7.56K
MMT
6434
Aberdeen Multi-Market Income Fund
MMT
$237M
$667 ﹤0.01%
+142
New +$650
RBOT
6435
DELISTED
Vicarious Surgical
RBOT
$661 ﹤0.01%
88
+7
+9% +$51
OFS icon
6436
OFS Capital
OFS
$44.1M
$658 ﹤0.01%
+78
New +$671
AVES icon
6437
Avantis Emerging Markets Value ETF
AVES
$1.42B
$643 ﹤0.01%
+12
New +$595
FTF
6438
Franklin Limited Duration Income Trust
FTF
$232M
$642 ﹤0.01%
+100
New +$632
CTMX icon
6439
CytomX Therapeutics
CTMX
$714M
$638 ﹤0.01%
281
-105,013
-100% -$169K
BCI icon
6440
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.96B
$623 ﹤0.01%
30
-426
-93% -$8.84K
PLUR icon
6441
Pluri
PLUR
$16.8M
$620 ﹤0.01%
125
APLT
6442
DELISTED
Applied Therapeutics
APLT
$617 ﹤0.01%
1,984
-51,923
-96% -$20.1K
DLTH icon
6443
Duluth Holdings
DLTH
$154M
$617 ﹤0.01%
294
-1,729
-85% -$3.25K
AADR icon
6444
AdvisorShares Dorsey Wright ADR ETF
AADR
$39.6M
$615 ﹤0.01%
7
SOPH icon
6445
SOPHiA GENETICS
SOPH
$483M
$614 ﹤0.01%
+198
New +$590
ZEPP
6446
Zepp Health
ZEPP
$64.8M
$614 ﹤0.01%
231
-5
-2% -$13
BGX
6447
Blackstone Long-Short Credit Income Fund
BGX
$136M
$608 ﹤0.01%
+49
New +$591
CGC
6448
Canopy Growth
CGC
$388M
$605 ﹤0.01%
496
OSTX
6449
OS Therapies Inc
OSTX
$71M
$605 ﹤0.01%
+322
New +$542
HCM icon
6450
HUTCHMED
HCM
$1.87B
$602 ﹤0.01%
40

Similar funds

JP Morgan Chase's Q2 2025 Portfolio in Review

As of Q2 2025, JP Morgan Chase held 7,888 positions worth $1.53T, up 12% from $1.37T the previous quarter. Its ten largest holdings account for 25% of the portfolio.

JP Morgan Chase's Q2 2025 filing shows 634 new, 2,517 increased, 3,216 reduced and 856 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.6B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • JP Morgan Chase's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M.
  • JP Morgan Chase added most to Microsoft in Q2 2025, an estimated $6.54B increase.
  • JP Morgan Chase's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.6B.
  • JP Morgan Chase fully exited Discover Financial Services in Q2 2025, selling an estimated $370M.
  • JP Morgan Chase's ten largest holdings make up 25% of its $1.53T portfolio in Q2 2025.
  • JP Morgan Chase opened 634 new positions and closed 856 in Q2 2025.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $1.53T.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.